KRAS and familial pancreatic carcinoma: In particular, KRAS plays a significant role in pancreatic cancer due to the dysregulation of key cellular processes including glycolysis, autophagy and macropinocytosis by altering cellular metabolism and supporting the tumor microenvironment [5,6,7].